Censo Biotechnologies offers specialist CNS focused discovery services using our human iPSC based neuro-degenerative and neuro-inflammatory platforms.
We provide access to a diverse range of existing human iPSC lines including both healthy and disease specific mutations. We can gene edit these lines to knock in, knock out or correct target genes of interest, and have developed reproducible differentiation protocols for a number of lineages.
Using these cells we offer both customised and standard phenotypic assays to deliver disease relevant compound characterisation, providing new insights and functional disease related understanding of our client's compounds.
Roslin, Edinburgh, EH25 9RE United Kingdom